[Speech apraxia in dialysis-associated aluminum encephalopathy].
A 57-year-old man on long-term renal dialysis presented with speech dyspraxia, a symptom characteristic of early aluminium encephalopathy. Once fully developed, this condition has a poor prognosis despite deferoxamine (DFO) treatment.
Haug
B A
BA
Abteilung Neurologie, Georg-August-Universität Göttingen.
Botsch
G
G
Felgenhauer
K
K
D000535:Aluminum / Q000493:pharmacokinetics / Q000506:poisoning*; D001072:Apraxias / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D015913:Chelation Therapy; D003676:Deferoxamine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D013342:Stuttering / Q000097:blood / Q000139:chemically induced* / Q000628:therapy
D000535:Aluminum; D003676:Deferoxamine
Sprechapraxie bei dialyseassoziierter Aluminiumenzephalopathie.